Jazz Pharmaceuticals PLC (JAZZ)

Payables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cost of revenue (ttm)	US$ in thousands	1,951,870	1,924,864	2,095,029	2,117,052	2,150,256	2,185,072	2,075,393	2,129,983	1,977,776	1,736,145	1,486,405	1,171,266	1,249,952	1,323,470	1,291,100	1,274,310	1,091,756	739,451	528,632	330,140
Payables	US$ in thousands	102,750	109,850	98,428	125,454	90,758	102,249	74,161	73,336	100,298	63,815	64,826	77,738	26,945	67,063	50,043	66,308	45,732	70,104	82,222	42,669
Payables turnover		19.00	17.52	21.28	16.88	23.69	21.37	27.98	29.04	19.72	27.21	22.93	15.07	46.39	19.73	25.80	19.22	23.87	10.55	6.43	7.74

December 31, 2023 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $1,951,870K ÷ $102,750K
= 19.00

The payables turnover ratio for Jazz Pharmaceuticals plc has shown fluctuating trends over the past eight quarters. In Q1 2022, the company had a payables turnover ratio of 7.03, which decreased to 7.02 in Q2 2022. However, the ratio then increased to 4.98 in Q3 2022 before rising again to 5.96 in Q4 2022.

In the first quarter of 2023, the payables turnover ratio decreased to 4.41 before increasing to 5.36 in Q2 2023. This upward trend continued with a ratio of 4.51 in Q3 2023. However, in Q4 2023, the ratio decreased to 4.24.

Overall, the payables turnover ratio for Jazz Pharmaceuticals plc has demonstrated some variability, indicating changes in the company's ability to efficiently manage its accounts payable and pay off its suppliers. It is crucial for the company to closely monitor this ratio to ensure effective cash flow management and maintain good relationships with its suppliers.